|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02415 MEDSCI
Nominal 
1.060 +0.070 (+7.071%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 260,623 | -25.364% | 349,194 | 348,950 | 297,731 | 215,854 |
| Cost of Sales | (98,449) | -25.748% | (132,587) | (142,629) | (107,921) | (98,822) |
| Gross Profit | 162,174 | -25.130% | 216,607 | 206,321 | 189,810 | 117,032 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (14,180) | 1606.378% | (831) | (111,884) | (197,134) | (507) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 25,497 | -57.821% | 60,450 | (96,292) | (147,058) | 33,173 | |
| Taxation | (530) | -90.200% | (5,408) | (3,589) | (3,972) | (4,259) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 24,967 | -54.640% | 55,042 | (99,881) | (151,030) | 28,914 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (16,045) | 6.293% | (15,095) | (10,022) | (4,574) | (1,048) |
| Depreciation & Amortisation | 7,195 | -13.832% | 8,350 | 8,378 | 8,476 | 7,105 |
| Directors' Emoluments | -- | -- | 5,351 | 3,650 | 2,610 | 2,167 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 5.000 | -54.545% | 11.000 | -21.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.073 | (0.030) | -- | -- |
| NBV per share ($) | 1.926 | -- | 1.845 | -- | -- | -- |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 24,967,000 |
| %Change | -54.640% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.926 |